Erlocip 150mg, 100mg Erlotinib Tablets

Erlocip 150mg, 100mg Erlotinib Tablets Specification

Indication
Non-small cell lung cancer

Dosage Form
Tablet

Salt Composition
Erlotinib 100mg / 150mg

Feature
Targeted therapy

Ingredients
Erlotinib hydrochloride

Application
Cancer therapy

Physical Color/Texture
White to off-white tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, dry place

Shelf Life
24 months

Pack Size
1*30 Tablet

Pack Type
Box

Prescription Status
Prescription only

Patient Group
Adults

Release Form
Immediate release

Tablet Shape
Film-coated tablet

Route
Oral use

Strength
100mg, 150mg

Brand Name
Erlocip

Erlocip 150mg, 100mg Erlotinib Tablets Trade Information

Minimum Order Quantity
1 Bottle

Supply Ability
5000 Bottles Per Month

Delivery Time
7 Days

About Erlocip 150mg, 100mg Erlotinib Tablets

Erlocip 150mg and 100mg Erlotinib Tablets offer a top-drawer solution for adults battling non-small cell lung cancer. Procured with immaculate precision, these film-coated, odorless tablets are available in cost-effective pack sizes of 1x30, ensuring competitive pricing for patients and healthcare providers alike. Sought-after for their targeted therapy benefits, Erlocip is intended for oral use and delivers immediate release of Erlotinib hydrochloride in either 100mg or 150mg strengths. Sourced from leading exporters, suppliers, traders, and wholesalers across India, Erlocip guarantees reliable quality and efficacy, provided strictly under prescription.

Purpose, Features, and Application

Erlocip 150mg and 100mg Erlotinib Tablets are specifically indicated for adult patients with non-small cell lung cancer, providing targeted therapy through oral administration. The film-coated, white to off-white tablets feature immediate-release technology for rapid action. Designed for efficient cancer therapy, these tablets are renowned for their high efficacy and impeccable quality. The main site of application is systemic, leveraging Erlotinib hydrochloride to antagonize tumor growth and progression in affected individuals.

Domestic Market, Sample Policy, and Certifications

Erlocip 150mg and 100mg Tablets serve a broad domestic market in India and are well-positioned for export market opportunities due to their demanding certifications. Potential partners can assess product integrity through a generous sample policy that ensures confidence before a significant drop-off in the asking price for bulk procurements. All batches conform to stringent certifications, making Erlocip a trusted choice for healthcare providers and traders alike.

FAQ's of Erlocip 150mg, 100mg Erlotinib Tablets:

Q: How should Erlocip 150mg or 100mg tablets be administered?

A: Erlocip tablets are intended for oral use only and should be taken exactly as prescribed by a healthcare professional, typically once daily on an empty stomach for optimum absorption.

Q: What is the main benefit of using Erlocip for cancer therapy?

A: Erlocip provides targeted therapy designed to impede the growth and spread of cancer cells in adult patients with non-small cell lung cancer, which can improve treatment outcomes.

Q: Where should Erlocip tablets be stored for maximum efficacy?

A: The tablets should be kept below 30C in a dry place to preserve their stability and ensure efficacy throughout the 24-month shelf life.

Q: When might a patient expect to see results from Erlocip treatment?

A: Results may vary, but improvements are often monitored through regular medical assessments conducted by healthcare professionals over the course of therapy.

Q: What certifications does Erlocip possess for ensuring quality?

A: All Erlocip batches meet rigorous quality and safety standards, inclusive of essential pharmaceutical certifications, to guarantee reliable and effective therapy.

Q: Who is eligible to use Erlocip 150mg or 100mg tablets?

A: Erlocip is indicated for use in adult patients diagnosed with non-small cell lung cancer, and it should only be used with a prescription from a qualified healthcare provider.

Tell us about your requirement